A recent study led by researchers from the Dana-Farber Cancer Institute has illuminated the potential of compounds capable of obstructing the “landing gear” of harmful viruses, including the one responsible for COVID-19. This discovery has led to the initiation of human clinical trials for a compound known as a “stapled lipopeptide.” If proven effective as a nasal spray, this compound could revolutionise COVID-19 prevention and treatment. Moreover, these stapled lipopeptides hold promise beyond COVID-19, as they may combat other dangerous viruses such as RSV, Ebola, and Nipah. 

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever